{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T23:53:51Z","timestamp":1774396431791,"version":"3.50.1"},"reference-count":47,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:00:00Z","timestamp":1767916800000},"content-version":"vor","delay-in-days":14,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,26]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Engagement in pre-exposure prophylaxis (PrEP) care and routine screening for HIV and sexually transmitted infections (STIs) is critical to realizing the full benefits of this HIV prevention strategy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We enrolled a cohort of individuals seeking PrEP services in two clinics in Missouri, an Ending the HIV Epidemic priority state, from June 2014 to November 2021. We used electronic health record and survey data to explore outcomes in the 2 years following linkage to care using multistate methods. We assessed transitions between eight mutually exclusive care states differentiated by receipt of a prescription, lab coverage status, and retention. We describe outcomes in the population overall and distinct sociodemographic subgroups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 470 individuals were included (90.3% male; median age 29 (IQR, 25\u201336); 52.9% White, non-Hispanic) and contributed 879.5 person-years of follow-up. One week following linkage to care, 86.8% (95% CI: 83.6\u201390.0) of participants had a PrEP prescription. At month 6, 35.2% (95% CI: 30.7\u201339.7) were in care but had a lapse in HIV\/STI screening, at month 12, 48.3% (95% CI: 43.7\u201353.1) were disengaged from care. Of those who disengaged, 28.3% (95% CI: 23.9\u201332.7) were re-engaged 6 months later. Females and uninsured individuals were the most likely to disengage during the first year of follow-up.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Lapses in clinic visits and lab screening are common among PrEP users in Missouri and most who disengage do not return. Females, uninsured individuals, and other marginalized groups may be particularly susceptible to poor persistence suggesting targeted interventions are warranted.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ofid\/ofaf795","type":"journal-article","created":{"date-parts":[[2025,12,21]],"date-time":"2025-12-21T12:41:12Z","timestamp":1766320872000},"source":"Crossref","is-referenced-by-count":1,"title":["PrEParing for Long-acting Technologies: A Multistate Analysis of PrEP Persistence and HIV and STI Lab Coverage Among Oral PrEP Initiators in St. Louis, Missouri (2014\u20132021)"],"prefix":"10.1093","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0355-4477","authenticated-orcid":false,"given":"Lindsey M","family":"Filiatreau","sequence":"first","affiliation":[{"name":"School of Public Health, Washington University in St. Louis , St. Louis, Missouri ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rupa","family":"Patel","sequence":"additional","affiliation":[{"name":"Community Health Department, Whitman Walker Health , Washington, District of Columbia ,","place":["USA"]},{"name":"Division of Infectious Diseases, School of Medicine, Washington University in St. Louis , St. Louis, Missouri ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9727-2066","authenticated-orcid":false,"given":"Kate","family":"Curoe","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, School of Medicine, Washington University in St. Louis , St. Louis, Missouri ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashley","family":"Underwood","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, School of Medicine, Washington University in St. Louis , St. Louis, Missouri ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Cherabie","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, School of Medicine, Washington University in St. Louis , St. Louis, Missouri ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0825-1424","authenticated-orcid":false,"given":"Elvin H","family":"Geng","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, School of Medicine, Washington University in St. Louis , St. Louis, Missouri ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0843-1414","authenticated-orcid":false,"given":"Aditi","family":"Ramakrishnan","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, School of Medicine, Washington University in St. Louis , St. Louis, Missouri ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5469-0727","authenticated-orcid":false,"given":"Rachel","family":"Presti","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, School of Medicine, Washington University in St. Louis , St. Louis, Missouri ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3787-365X","authenticated-orcid":false,"given":"Aaloke","family":"Mody","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, School of Medicine, Washington University in St. Louis , St. Louis, Missouri ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2026,1,9]]},"reference":[{"key":"2026011607115960500_ofaf795-B1","doi-asserted-by":"crossref","first-page":"e26034","DOI":"10.1002\/jia2.26034","article-title":"The impact of prevention-effective PrEP use on HIV incidence: a mathematical modelling study.","volume":"25","author":"Roberts","year":"2022","journal-title":"J Int AIDS Soc"},{"key":"2026011607115960500_ofaf795-B2","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1093\/cid\/ciz896","article-title":"Pre-exposure prophylaxis persistence is a critical issue in PrEP implementation","volume":"71","author":"Spinelli","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2026011607115960500_ofaf795-B3","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.annepidem.2025.04.017","article-title":"Estimating the population need for preexposure prophylaxis for HIV in the United States","volume":"106","author":"Kourtis","year":"2025","journal-title":"Ann Epidemiol"},{"key":"2026011607115960500_ofaf795-B4","doi-asserted-by":"crossref","first-page":"e26459","DOI":"10.1002\/jia2.26459","article-title":"Inequities in PrEP annualized pill-day coverage, United States, 2018\u20132022: a cross-sectional pharmacoequity analysis","volume":"28","author":"Sullivan","year":"2025","journal-title":"J Int AIDS Soc"},{"key":"2026011607115960500_ofaf795-B5","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1093\/cid\/ciaa037","article-title":"Persistence with human immunodeficiency virus pre-exposure prophylaxis in the United States, 2012\u20132017","volume":"72","author":"Huang","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2026011607115960500_ofaf795-B6","doi-asserted-by":"crossref","first-page":"e25252","DOI":"10.1002\/jia2.25252","article-title":"Persistence on HIV preexposure prophylaxis medication over a 2-year period among a national sample of 7148 PrEP users, United States, 2015 to 2017","volume":"22","author":"Coy","year":"2019","journal-title":"J Int AIDS Soc"},{"key":"2026011607115960500_ofaf795-B7","doi-asserted-by":"crossref","first-page":"e5729","DOI":"10.1002\/pds.5729","article-title":"Adherence and persistence of HIV pre-exposure prophylaxis use in the United States","volume":"33","author":"McCormick","year":"2024","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2026011607115960500_ofaf795-B8","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1093\/cid\/ciz894","article-title":"Pre-exposure prophylaxis uptake and discontinuation among young black men who have sex with men in Atlanta, Georgia: a prospective cohort study","volume":"71","author":"Serota","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2026011607115960500_ofaf795-B9","doi-asserted-by":"crossref","first-page":"e2122692","DOI":"10.1001\/jamanetworkopen.2021.22692","article-title":"Characterization of HIV preexposure prophylaxis use behaviors and HIV incidence among US adults in an integrated health care system","volume":"4","author":"Hojilla","year":"2021","journal-title":"JAMA Netw Open"},{"key":"2026011607115960500_ofaf795-B10","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1089\/apc.2022.0169","article-title":"Back2PrEP: rates of bacterial sexually transmitted infection diagnosis among individuals returning to HIV Pre-exposure prophylaxis care: a retrospective review of a New York city comprehensive HIV prevention program","volume":"36","author":"McLean","year":"2022","journal-title":"AIDS Patient Care STDS"},{"key":"2026011607115960500_ofaf795-B11","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1186\/s12889-023-16353-9","article-title":"Understanding the effects of universal test and treat on longitudinal HIV care outcomes among South African youth: a retrospective cohort study","volume":"23","author":"Filiatreau","year":"2023","journal-title":"BMC Public Health"},{"key":"2026011607115960500_ofaf795-B12","doi-asserted-by":"crossref","first-page":"e561","DOI":"10.1093\/cid\/ciaa268","article-title":"Longitudinal care cascade outcomes among people eligible for antiretroviral therapy who are newly linking to care in Zambia: a multistate analysis","volume":"71","author":"Mody","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2026011607115960500_ofaf795-B13","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.annepidem.2023.07.002","article-title":"Alcohol use and the longitudinal HIV care continuum for people with HIV who enrolled in care between 2011 and 2019","volume":"85","author":"Lesko","year":"2023","journal-title":"Ann Epidemiol"},{"key":"2026011607115960500_ofaf795-B14","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1186\/s12889-018-5688-y","article-title":"Progression of diabetes, ischemic heart disease, and chronic kidney disease in a three chronic conditions multistate model","volume":"18","author":"Siriwardhana","year":"2018","journal-title":"BMC Public Health"},{"key":"2026011607115960500_ofaf795-B15","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s11904-021-00561-2","article-title":"Novel longitudinal methods for assessing retention in care: a synthetic review","volume":"18","author":"Mody","year":"2021","journal-title":"Curr HIV\/AIDS Rep"},{"key":"2026011607115960500_ofaf795-B16","doi-asserted-by":"crossref","first-page":"ofae584","DOI":"10.1093\/ofid\/ofae584","article-title":"Understanding typology of preexposure prophylaxis (PrEP) persistence trajectories among male PrEP users in the United States","volume":"11","author":"Chen","year":"2024","journal-title":"Open Forum Infect Dis"},{"key":"2026011607115960500_ofaf795-B17","doi-asserted-by":"crossref","first-page":"e1003651","DOI":"10.1371\/journal.pmed.1003651","article-title":"The revolving door of HIV care: revising the service delivery cascade to achieve the UNAIDS 95-95-95 goals","volume":"18","author":"Ehrenkranz","year":"2021","journal-title":"PLoS Med"},{"key":"2026011607115960500_ofaf795-B18","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.cmpb.2010.01.001","article-title":"The mstate package for estimation and prediction in non- and semi-parametric multi-state and competing risks models","volume":"99","author":"de Wreede","year":"2010","journal-title":"Comput Methods Programs Biomed"},{"key":"2026011607115960500_ofaf795-B19","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1089\/apc.2022.0004","article-title":"Lost2PrEP: understanding reasons for Pre-exposure prophylaxis and sexual health care disengagement among men who have sex with men attending a sexual health clinic at a large urban academic medical center in New York city","volume":"36","author":"Rowe","year":"2022","journal-title":"AIDS Patient Care STDS"},{"key":"2026011607115960500_ofaf795-B20","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1007\/s10508-024-02862-0","article-title":"Factors associated with PrEP persistence and loss of follow-up: a 5-year historic cohort","volume":"53","author":"Le Roux","year":"2024","journal-title":"Arch Sex Behav"},{"key":"2026011607115960500_ofaf795-B21","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1093\/aje\/kwaa286","article-title":"The clinical course of coronavirus disease 2019 in a US hospital system: a multistate analysis","volume":"190","author":"Mody","year":"2021","journal-title":"Am J Epidemiol"},{"key":"2026011607115960500_ofaf795-B22","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1191\/0962280202SM276ra","article-title":"Multi-state models for event history analysis","volume":"11","author":"Andersen","year":"2002","journal-title":"Stat Methods Med Res"},{"key":"2026011607115960500_ofaf795-B23","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s40471-022-00291-y","article-title":"The utility of multistate models: a flexible framework for time-to-event data","volume":"9","author":"Le-Rademacher","year":"2022","journal-title":"Curr Epidemiol Rep"},{"key":"2026011607115960500_ofaf795-B24","doi-asserted-by":"crossref","first-page":"e254","DOI":"10.1016\/S2352-3018(22)00030-3","article-title":"Discontinuation, suboptimal adherence, and reinitiation of oral HIV pre-exposure prophylaxis: a global systematic review and meta-analysis","volume":"9","author":"Zhang","year":"2022","journal-title":"Lancet HIV"},{"key":"2026011607115960500_ofaf795-B25","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/QAI.0000000000002954","article-title":"A pilot study of a patient navigation intervention to improve HIV pre-exposure prophylaxis persistence among Black\/African American men who have sex with men","volume":"90","author":"Goedel","year":"2022","journal-title":"JAIDS J Acquir Immune Defic Syndr"},{"key":"2026011607115960500_ofaf795-B26","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1016\/j.amepre.2021.04.036","article-title":"Pre-exposure prophylaxis uptake, adherence, and persistence: a narrative review of interventions in the U.S","volume":"61","author":"Garrison","year":"2021","journal-title":"Am J Prev Med"},{"key":"2026011607115960500_ofaf795-B27","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1186\/s12889-023-16072-1","article-title":"Persistence in a pharmacist-led, same-day PrEP program in Mississippi: a mixed-methods study","volume":"23","author":"Khosropour","year":"2023","journal-title":"BMC Public Health"},{"key":"2026011607115960500_ofaf795-B28","doi-asserted-by":"crossref","first-page":"e130","DOI":"10.1016\/S2352-3018(20)30307-6","article-title":"Effect of SMS reminders on PrEP adherence in young Kenyan women (MPYA study): a randomised controlled trial","volume":"8","author":"Haberer","year":"2021","journal-title":"Lancet HIV"},{"key":"2026011607115960500_ofaf795-B29","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1007\/s10461-024-04387-y","article-title":"Assessing structural racism and discrimination along the pre-exposure prophylaxis continuum: a systematic review","volume":"28","author":"Seyedroudbari","year":"2024","journal-title":"AIDS Behav"},{"key":"2026011607115960500_ofaf795-B30","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1097\/QAI.0000000000003005","article-title":"A demedicalized model to provide PrEP in a sexual health clinic","volume":"90","author":"Ramchandani","year":"2022","journal-title":"JAIDS J Acquir Immune Defic Syndr"},{"key":"2026011607115960500_ofaf795-B31","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/hiv.13451","article-title":"Long-acting injectable cabotegravir for PrEP: a game-changer in HIV prevention?","volume":"24","author":"Liegeon","year":"2023","journal-title":"HIV Med"},{"key":"2026011607115960500_ofaf795-B32","doi-asserted-by":"crossref","first-page":"e26103","DOI":"10.1002\/jia2.26103","article-title":"Preparing for long-acting PrEP delivery: building on lessons from oral PrEP","volume":"26","author":"Celum","year":"2023","journal-title":"J Int AIDS Soc"},{"key":"2026011607115960500_ofaf795-B33","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1089\/apc.2022.0111","article-title":"Preferences across pre-exposure prophylaxis modalities among young men who have sex with men in the United States: a latent class analysis study","volume":"36","author":"Valente","year":"2022","journal-title":"AIDS Patient Care STDS"},{"issue":"S2","key":"2026011607115960500_ofaf795-B34","doi-asserted-by":"crossref","first-page":"e26096","DOI":"10.1002\/jia2.26096","article-title":"Who prefers what? Correlates of preferences for next-generation HIV prevention products among a national U.S. sample of young men who have sex with men","volume":"26","author":"Biello","year":"2023","journal-title":"J Int AIDS Soc"},{"key":"2026011607115960500_ofaf795-B35","first-page":"149","article-title":"Can we screen less frequently for STI among PrEP users? Assessing the effect of biannual STI screening on timing of diagnosis and transmission risk in the AMPrEP study","volume":"99","author":"Jongen","year":"2023","journal-title":"Sex Transm Infect"},{"key":"2026011607115960500_ofaf795-B36","doi-asserted-by":"crossref","first-page":"e26115","DOI":"10.1002\/jia2.26115","article-title":"Advancing the use of long-acting extended delivery formulations for HIV prevention in sub-Saharan Africa: challenges, opportunities, and recommendations","volume":"26","author":"Mgodi","year":"2023","journal-title":"J Int AIDS Soc"},{"key":"2026011607115960500_ofaf795-B37","doi-asserted-by":"crossref","first-page":"e711","DOI":"10.1016\/S2352-3018(24)00173-5","article-title":"The long wait for long-acting HIV prevention and treatment formulations","volume":"11","author":"Venter","year":"2024","journal-title":"Lancet HIV"},{"key":"2026011607115960500_ofaf795-B38"},{"key":"2026011607115960500_ofaf795-B39","doi-asserted-by":"crossref","first-page":"4102","DOI":"10.1007\/s10461-021-03267-z","article-title":"Differences in PrEP awareness, discussions with healthcare providers, and use among men who have sex with men in the United States by urbanicity and region: a cross-sectional analysis","volume":"25","author":"Rossiter","year":"2021","journal-title":"AIDS Behav"},{"key":"2026011607115960500_ofaf795-B40","first-page":"100738","article-title":"Equity of PrEP uptake by race, ethnicity, sex and region in the United States in the first decade of PrEP: a population-based analysis","volume":"33","author":"Sullivan","year":"2024","journal-title":"Lancet Reg Health\u2014Am"},{"key":"2026011607115960500_ofaf795-B41","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/QAI.0000000000002952","article-title":"Reasons for PrEP discontinuation after navigation at sexual health clinics: interactions among systemic barriers, behavioral relevance, and medication concerns","volume":"90","author":"Unger","year":"2022","journal-title":"JAIDS J Acquir Immune Defic Syndr"},{"key":"2026011607115960500_ofaf795-B42","doi-asserted-by":"crossref","first-page":"e0241477","DOI":"10.1371\/journal.pone.0241477","article-title":"Understanding patient transfers across multiple clinics in Zambia among HIV infected adults","volume":"15","author":"Sikombe","year":"2020","journal-title":"PLoS One"},{"key":"2026011607115960500_ofaf795-B43","doi-asserted-by":"crossref","first-page":"e070384","DOI":"10.1136\/bmjopen-2022-070384","article-title":"Estimating potential silent transfer using baseline viral load measures among people presenting as new to HIV care in Lusaka, Zambia: a cross-sectional study","volume":"13","author":"Pry","year":"2023","journal-title":"BMJ open"},{"key":"2026011607115960500_ofaf795-B44","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1007\/s11121-022-01397-x","article-title":"Texting lost-to-follow-up PrEP patients from a San Francisco sexual health clinic","volume":"23","author":"Johnson","year":"2022","journal-title":"Prev Sci"},{"key":"2026011607115960500_ofaf795-B45","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/QAI.0b013e3181b843f0","article-title":"Understanding reasons for and outcomes of patients lost to follow-up in antiretroviral therapy programs in Africa through a sampling-based approach","volume":"53","author":"Geng","year":"2010","journal-title":"JAIDS J Acquir Immune Defic Syndr"},{"key":"2026011607115960500_ofaf795-B46","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1093\/cid\/civ1004","article-title":"Retention in care and patient-reported reasons for undocumented transfer or stopping care among HIV-infected patients on antiretroviral therapy in Eastern Africa: application of a sampling-based approach","volume":"62","author":"Geng","year":"2016","journal-title":"Clin Infect Dis"},{"key":"2026011607115960500_ofaf795-B47","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1001\/jama.300.5.506","article-title":"Sampling-based approach to determining outcomes of patients lost to follow-up in antiretroviral therapy scale-up programs in Africa","volume":"300","author":"Geng","year":"2008","journal-title":"JAMA"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ofid\/advance-article-pdf\/doi\/10.1093\/ofid\/ofaf795\/66320902\/ofaf795.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/13\/1\/ofaf795\/66320902\/ofaf795.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/13\/1\/ofaf795\/66320902\/ofaf795.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T12:12:06Z","timestamp":1768565526000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofaf795\/8417805"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,26]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12,26]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofaf795","relation":{},"ISSN":["2328-8957"],"issn-type":[{"value":"2328-8957","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,1]]},"published":{"date-parts":[[2025,12,26]]},"article-number":"ofaf795"}}